Home/Filings/4/0001209191-21-054953
4//SEC Filing

Liberto Erin 4

Accession 0001209191-21-054953

CIK 0001762303other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 4:05 PM ET

Size

9.9 KB

Accession

0001209191-21-054953

Insider Transaction Report

Form 4
Period: 2021-05-18
Liberto Erin
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2021-07-06+10,50010,500 total
  • Award

    Stock Options (Right to Buy)

    2021-05-18+6,00030,000 total
    Exercise: $5.03Exp: 2027-09-06Common Stock (6,000 underlying)
  • Award

    Stock Options (Right to Buy)

    2021-07-06+6,9256,925 total
    Exercise: $20.21Exp: 2031-07-06Common Stock (6,925 underlying)
Footnotes (3)
  • [F1]Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.
  • [F2]These Stock Options were originally granted on September 6, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.
  • [F3]These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.

Issuer

AVITA Medical, Inc.

CIK 0001762303

Entity typeother

Related Parties

1
  • filerCIK 0001816245

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:05 PM ET
Size
9.9 KB